KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories Takes Next Step in Launching Spydasilk™ Apparel Brand

Kraig Biocraft Laboratories Takes Next Step in Launching Spydasilk™ Apparel Brand

ANN ARBOR, Mich., June 27, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that, in collaboration with its joint venture partner, Kings Group, the Company has selected a high-quality garment manufacturer to produce Spydasilk'sTM first apparel line.

Over the course of multiple meetings between Kraig Labs, Kings Group, and the garment manufacturer, conducted while the Company's COO was in Vietnam this month, the Company finalized its manufacturer choice for the first apparel launch under the SpydasilkTM brand.

The manufacturer selected has demonstrated its capacity and technical ability to deliver on Spydasilk's vision for apparel that blends performance and elegance with its exclusive spider silk materials. With more than 20 years in business and its strong ties to Vietnam's entire textile supply chain, this producer can leverage the capabilities of the best mills to bring the Spydasilk brand to life.

In partnership with Kings Group, the Company has already delivered its recombinant spider silk yarn and a non-spider silk fabric swatch for use in developing a brand new fabric built upon the performance and feel of the Company's spider silk.

"Bringing the first products built on our spider silk technology to life is a critical step we are taking simultaneously with our planned increase in production through third-party contractors," said Company COO, Jon Rice. "The network we have assembled to launch Spydasilk brings together top textile science, fashion, marketing, and branding experts. Our vision for the mass production and distribution of products built upon the amazing capabilities of spider silk is now quickly becoming a reality."

Kraig Labs and Kings Group are simultaneously developing an accelerated product launch plan, including media, marketing, sales, and distribution systems for this first direct-to-consumer apparel launch.

The Company expects to continue to provide additional details and updates on the rapid advancements it is making under its business plan. Further information will be shared in press releases on advancements in production, quality control, and end market products over the coming days and weeks.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to .

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495



EN
27/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

Kraig Biocraft Laboratories Announces Senior Management Trip to Southe...

Kraig Biocraft Laboratories Announces Senior Management Trip to Southeast Asia to Oversee Expansion of Spider Silk Production ANN ARBOR, Mich., June 10, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that senior management will travel to Southeast Asia this week to oversee the continued expansion of the Company's recombinant spider silk production operations. This strategic visit is designed to support and accelerate the Company’s 2025 production scale-up. In addition to reinforc...

 PRESS RELEASE

Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent ...

Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025 ANN ARBOR, Mich., June 03, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, issues a letter to shareholders. Dear Shareholders, We recently received inquiries from several of our shareholders. In preparing those responses, we realized that we should share the contents with the broader Kraig Labs community. Many had questions related to last week's annou...

 PRESS RELEASE

Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain ...

Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain for Expanded Commercial Production Company Expands Capacity to Meet Material Demand and Scale Inventory by developing new parental Strain for Production ANN ARBOR, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces today the successful development of a new recombinant spider silk parental line, purpose-built for large-scale commercial production. This newly developed strain represents the third com...

 PRESS RELEASE

Kraig Biocraft Laboratories Receives Business License to Begin Operati...

Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia New Location to Support Unprecedented 2025 Spider Silk Production Expansion ANN ARBOR, Mich., May 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, announces today that it has officially received its business license to begin operations in the Kingdom of Cambodia. This milestone marks a significant step in the Company’s ongoing strategy to scale up and diversify its production capabilities in response to ...

 PRESS RELEASE

Kraig Biocraft Laboratories Successfully Completes March/April Product...

Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway Company Continues to Meet 2025 Scale-Up Targets ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk production run and is currently well underway with its May production cycle. This steady progress reflects the Company's continued execution against its 2025 production scale-up plan,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch